Psychedelic Business Spotlight – February 4
Levitee Labs Announces Interim CEO and Board of Directors Shuffle…
psilocybin
How Psychedelic Treatment Through Canada’s SAP Works
Two psychedelic industry insiders reflect on the progress and flaws within Health Canada’s recent amendment to the Special Access Program.
Why Mindset Pharma’s Deal with Big Pharma Is a Big Deal for Psychedelics
The partnership with global pharmaceutical company Otsuka positions the psychedelic medicine company as a leader in the industry.
Psychedelic Business Spotlight — January 28
This week in psychedelic business news: A major player begins manufacturing; another rebrands; and one of the biggest gets bigger.
Colorado Lawmakers and Activists Push for Wide-Ranging Psychedelic Reform
Trio of lawmakers propose a psychedelic reform review panel, while two ballot initiatives push legalization and licensed “healing centers.”
Oklahoma GOP Lawmakers Push for Psychedelic Reform
Biggest difference between the two proposed bills: one decriminalizes plant medicine.
How to Prepare for Your First Psychedelic Trip in 5 Easy Steps
Psilocybin and LSD are becoming more popular and more accessible, but before your first psychedelic trip, it is essential to prepare.
Psychedelic Business Spotlight – January 21
Catch up on some of the biggest psychedelic business developments that unfolded in the last week.
Majority of Mental Health Patients Support Access to Psychedelics, Survey Finds
Americans continue to open their minds to ketamine, psilocybin, and MDMA treatment for depression, anxiety, and PTSD.
Psychedelics ‘Train Has Left the Station’ Says Federal Drug Official as More States Seek Access
A Republican in Missouri and two Democrats in Virginia file bills that push the psychedelics movement forward.
End of content
End of content